亚太药业：控股股东将变更为星浩控股 10月14日复牌

Core Viewpoint - Asia-Pacific Pharmaceutical (002370) announced a share transfer agreement where its controlling shareholder, Fubon Group, will transfer 14.62% of its shares, totaling 109 million shares, to Xinghao Holdings at a price of 8.26 CNY per share, amounting to a total of 900 million CNY [1] Group 1 - The share transfer will change the controlling shareholder from Fubon Group to Xinghao Holdings, with the actual controllers shifting from a management team to Qiu Zhongxun [1] - The company's stock will resume trading on October 14 following the announcement [1] Group 2 - Asia-Pacific Pharmaceutical plans to issue shares to Xinghao Holdings at a price of 5.11 CNY per share, raising up to 700 million CNY, which will be used entirely for new drug research and development projects after deducting related issuance costs [1]